期刊发表_期刊投稿_问题解决平台

一审返修

一审返修后，一直with editor是啥情况？难道换责任编辑了，就没人管了？也不再给原评审人看看了？够命运多舛的了，祈祷顺利一点吧！

散币祈福！第二篇文章Decision in process状态

求求编辑手下留情放过我放过我

广东化工

《广东化工》编辑太LJ了。根本不问学术，一心捞钱。若我说错了，请指正

水资源与水工程学报审稿

请问大家，论文已经投了快一个半月了，一直都是已发回执状态，是什么情况啊

论文要投稿了，希望能送审，最好也能中，祈福中。

完美汉化！这才是最值得推荐的EndNote X9

EndNote是非常受欢迎的文献管理软件，上手快、效率高。很多童鞋反映希望能切换为中文界面，这样使用起来更轻松。

今天就奉上EndNote X9完美汉化版，快来试试吧~

跪求一个校园网账号

跪求一个校园网账号，想下载文章，最近写文章，用一周左右。

ACS一审回复后编辑回复重复率太高，求助解决这个问题的流程和办法。

ACS SUSTAIN CHEM ENG 编辑让降低重复率，具体降到多少？已经修回6天啦。。。。忐忑

认真修改了手稿，并重点修订了实验部分。当时也没有查重就直接修回啦。。。。。。。。。。。现在好怕

这是编辑的邮件信息
The reviewers have reviewed your manuscript and have no further comments to address. However, in our editorial review, we find that your manuscript contains substantial content that is taken verbatim from your previously published work and contains overlap with previously published material. Consequently, I am asking for a revision to address this overlap. The primary areas of concern within the main text are the Experimental section.

Please review the Similarity Report, link provided, and revise your paper to avoid overlap. When your revision is submitted, it will again be checked for overlap with published content.

When resubmitting your manuscript, you should provide an explanation in your cover letter that addresses the changes you have made. Until we receive your revision, we cannot proceed further with the review of your manuscript.

Please note that all authors are responsible for the originality of the content presented for publication. We require that all authors listed on a manuscript take responsibility for its submission. I ask that you, as corresponding author, discuss this communication with your co-authors, and respond on behalf of all authors.

The ACS Publications Ethical Guidelines clearly state that plagiarism, including copied figures and verbatim (or near-verbatim) text from other publications, is not acceptable without proper citation and permissions (please see the full guidelines here:

We would like to receive your revision as soon as possible, and no later than 05-Mar-2020.

We look forward to receiving your revised manuscript.